CANCER OF THE PROSTATE
Clinical trials for CANCER OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PROSTATE trials appear
Sign up with your email to follow new studies for CANCER OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in slowing prostate cancer growth
Disease control CompletedThis study tested a drug called enzalutamide in men with a type of prostate cancer that has stopped responding to hormone therapy but hasn't spread yet. The goal was to see if the drug could delay the cancer from spreading to other parts of the body. About 1,400 men took part, an…
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New radioactive cocktail shows promise for tough prostate cancers
Disease control CompletedThis study tested a radioactive drug (I-131-1095) plus a standard hormone therapy (enzalutamide) in 120 men with advanced prostate cancer that had stopped responding to another treatment (abiraterone). The goal was to see if the combination could shrink tumors and lower PSA level…
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
Real-world study tracks prostate cancer treatment duration
Knowledge-focused CompletedThis study reviewed medical records from over 1,300 men with metastatic castration-sensitive prostate cancer to see how long they actually take the drugs apalutamide or enzalutamide. It is not a clinical trial but an observation of real-world treatment patterns. The goal is to un…
Matched conditions: CANCER OF THE PROSTATE
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC